How big is the Global Brucellosis Vaccines Market?

The Global Brucellosis Vaccines Market size is expected to reach USD 257.35 million in 2024 and grow at a CAGR of 6.20% to reach USD 347.65 million by 2029. Read More

What is the current Global Brucellosis Vaccines Market size?

In 2024, the Global Brucellosis Vaccines Market size is expected to reach USD 257.35 million. Read More

Who are the key players in Global Brucellosis Vaccines Market?

Merck & Co., Inc., Ceva, CZ Vaccines, Hester Biosciences Limited and Laboratories Tornel are the major companies operating in the Global Brucellosis Vaccines Market. Read More

Which is the fastest growing region in Global Brucellosis Vaccines Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Brucellosis Vaccines Market?

In 2024, the North America accounts for the largest market share in Global Brucellosis Vaccines Market. Read More

What years does this Global Brucellosis Vaccines Market cover, and what was the market size in 2023?

In 2023, the Global Brucellosis Vaccines Market size was estimated at USD 241.39 million. The report covers the Global Brucellosis Vaccines Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Brucellosis Vaccines Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Brucellosis Vaccines Market Share

Statistics for the 2023 & 2024 Global Brucellosis Vaccines market share, created by Mordor Intelligence™ Industry Reports. Global Brucellosis Vaccines share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Brucellosis Vaccines Industry

Most players are based in developing countries due to the presence of large animal bases and agricultural environments. The market is partially fragmented, which makes it moderately competitive. Some companies currently dominating the market are Merck & Co. Inc., Ceva, CZ Vaccines, Laboratories Tornel, and Hester Biosciences Limited.